SNP array karyotyping allows for the detection of uniparental disomy and cryptic chromosomal abnormalities in MDS/MPD-U and MPD.

SNP array karyotyping allows for the detection of uniparental disomy and cryptic chromosomal abnormalities in MDS/MPD-U and MPD.
复制标题

DOI:
10.1371/journal.pone.0001225
复制
发表时间:
2007-11-21
期刊:
影响因子:
3.7
通讯作者:
Maciejewski JP
Maciejewski JP
中科院分区:
综合性期刊3区
文献类型:
--
作者:
Gondek LP;Dunbar AJ;Szpurka H;McDevitt MA;Maciejewski JP

文献摘要

参考文献

被引文献

相似文献

我们应用单核苷酸多态性阵列(SNP-A)研究非典型骨髓增殖性综合征(MPD)患者的核型异常,包括骨髓增殖性/骨髓增生异常综合征(MPD)患者JAK2 V617F突变和继发性急性髓系白血病(AML)的阳性和阴性重叠。在典型的MPD病例(N = 8)中,作为对照组,纯合V617F突变的患者使用SNP-A显示出明显的9p单系二体(UPD)。与可能的基因组不稳定性一致,在19/30的MDS/MPD-U患者中,我们发现了中期细胞遗传学未发现的额外病变。除了UPD9p,我们还检测到UPD影响其他染色体,包括1(2/30),11(4/30),12(1/30)和22(1/30)。30例患者中有8例转化为AML。在5名进展为AML的V617F+患者中,我们发现SNP-A可以检测两种转化模式:白血病母细胞从携带其他获得性染色体缺陷的野生型jak2前体进化而来,或者从以UPD9p为特征的V617F+突变祖细胞进化而来。基于snp检测MDS/MPD-U的隐性病变可能有助于解释该疾病的临床异质性。
We applied single nucleotide polymorphism arrays (SNP-A) to study karyotypic abnormalities in patients with atypical myeloproliferative syndromes (MPD), including myeloproliferative/myelodysplastic syndrome overlap both positive and negative for the JAK2 V617F mutation and secondary acute myeloid leukemia (AML). In typical MPD cases (N = 8), which served as a control group, those with a homozygous V617F mutation showed clear uniparental disomy (UPD) of 9p using SNP-A. Consistent with possible genomic instability, in 19/30 MDS/MPD-U patients, we found additional lesions not identified by metaphase cytogenetics. In addition to UPD9p, we also have detected UPD affecting other chromosomes, including 1 (2/30), 11 (4/30), 12 (1/30) and 22 (1/30). Transformation to AML was observed in 8/30 patients. In 5 V617F+ patients who progressed to AML, we show that SNP-A can allow for the detection of two modes of transformation: leukemic blasts evolving from either a wild-type jak2 precursor carrying other acquired chromosomal defects, or from a V617F+ mutant progenitor characterized by UPD9p. SNP-A-based detection of cryptic lesions in MDS/MPD-U may help explain the clinical heterogeneity of this disorder.
DOI: 10.1093/carcin/bgl086
发表时间: 2007-01-01
期刊: CARCINOGENESIS
影响因子: 4.7
作者:
Andersen, Claus Lindbjerg;Wiuf, Carsten;Orntoft, Torben Falck
通讯作者: Orntoft, Torben Falck
DOI: 10.1182/blood-2005-05-1898
发表时间: 2005-11-15
期刊: BLOOD
影响因子: 20.3
作者:
Levine, RL;Loriaux, M;Deininger, MWN
通讯作者: Deininger, MWN
DOI: 10.1038/sj.onc.1209163
发表时间: 2006-03-02
期刊: ONCOGENE
影响因子: 8
作者:
Lee, JW;Kim, YG;Lee, SH
通讯作者: Lee, SH
DOI: 10.1038/ng1416
发表时间: 2004-09-01
期刊: NATURE GENETICS
影响因子: 30.8
作者:
Iafrate, AJ;Feuk, L;Lee, C
通讯作者: Lee, C
DOI: 10.1016/s0889-8588(03)00087-x
发表时间: 2003-10-01
影响因子: 2.4
作者:
Adeyinka, A;Dewald, GW
通讯作者: Dewald, GW